Global Neurostimulation Devices Market

Neurostimulation Devices Market Size, Share, Growth Analysis, By Type(Implantable Devices and Non-Implantable Devices), By Application(Pain Management and Parkinson's Disease), By Region(North America, Europe, Asia Pacific, Middle East and Africa), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2087 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 88 | Figures: 76

Neurostimulation Devices Market Dynamics

Neurostimulation Devices Market Drivers

Rising Incidence of Neurological Disorders 

  • Poor lifestyle choices and the growing adoption of unhealthy habits have significantly increased the number of people suffering from neurological diseases. Growing incidence of Parkinson's disease, epilepsy, chronic pain, and depression are also contributing to the high demand for neurostimulation devices as they play a crucial role in the management and treatment of the conditions.

Growing Geriatric Population  

  • Increasing life expectancy around the world has led to a massive upsurge in the senior population. Old people are more at risk of developing neurological disorders such as dementia, Alzheimer's, and Parkinson’s, which makes them a key end user of neurostimulation devices. Hence, as the senescent population increases it is also expected to benefit neurostimulation devices market growth as well.  

Restraints 

Dearth of Skilled Medical Professionals 

  • Neurostimulation devices are highly advanced medical devices that require highly skilled medical professionals to operate. However, the world is facing a shortage of skilled workforce, and this trend is also true for the neurostimulation devices market as well. This absence of skilled medical professionals to use neurostimulation devices could impede market development potential going forward.  

Risk of Failure or Complications 

  • Even though neurostimulation devices are often used through minimally invasive procedures, they have multiple risks and complications associated with them. Infections, device malfunction, and adverse neurological effects are some key concerns that are expected to hamper the sales of neurostimulation devices across the study period. Addressing these concerns of risk and complications will be vital for market players in the future. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031). 

Neurostimulation device manufacturers should focus on making their products more affordable to increase their sales potential. Creating products with minimal risk of complications should also be a key area of interest for all neurostimulation devices companies. Targeting countries with rapidly increasing geriatric population will also offer attractive returns for all neurostimulation devices companies in the future.  'Medtronic (Ireland) ', 'Abbott Laboratories (US) ', 'Boston Scientific Corporation (US) ', 'LivaNova PLC (U.K.) ', 'Nevro Corp. (US) ', 'NeuroPace, Inc. (US) ', 'Synapse Biomedical Inc. (US) ', 'Neuronetics, Inc. (US) ', 'NDI Medical LLC (US) ', 'Stimwave Technologies (US) ', 'BioControl Medical (Israel) ', 'EndoStim (US) ', 'Aleva Neurotherapeutics (Switzerland) ', 'SPR Therapeutics (US) ', 'electroCore, Inc. (US) ', 'Soterix Medical Inc. (US) ', 'Cala Health (US ', 'Inspire Medical Systems, Inc. (US) ', 'NeuroSigma, Inc. (US) ', 'Autonomic Technologies Inc. (US) ', 'Axonics Modulation Technologies, Inc. (US) ', 'Nexstim Plc (Finland) '

Poor lifestyle choices and the growing adoption of unhealthy habits have significantly increased the number of people suffering from neurological diseases. Growing incidence of Parkinson's disease, epilepsy, chronic pain, and depression are also contributing to the high demand for neurostimulation devices as they play a crucial role in the management and treatment of the conditions.

Development of Personalized Neurostimulation: Preference of personalized medicine is increasing rapidly around the world and this trend has also reached the neurostimulation devices market. Neurostimulation devices can easily adapt to a patient's unique neurological patterns and are estimated to be highly popular in the future as they improve the effectiveness and efficiency of therapies for conditions like chronic pain and epilepsy.  

North America secures the top spot when it comes to global neurostimulation device demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and availability of favorable reimbursement for neurological procedures are helping this region maintain a high market share. The increasing geriatric population and high investments in neurological research are also expected to create new opportunities for suppliers of neurostimulation devices in this region. The United States and Canada are slated to be the top markets in North America for neurostimulation device providers going forward. Moreover, the presence of key medical device manufacturers in this region will also aid the dominance of North America going forward.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Neurostimulation Devices Market

Report ID: SQMIG35B2087

$5,300
BUY NOW GET FREE SAMPLE